News Quantified

QGEN – qiagen n.v. common shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Qiagen (NYSE:QGEN) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.

Qiagen (NYSE:QGEN) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.

Should You Continue to Hold Hologic Stock Post Q4 Earnings? [Yahoo! Finance]

QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025

QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase

-1.1%

BEAT

-4.9%

IN-LINE

-1.1%

BEAT

-3.1%

BEAT

Form SCHEDULE 13G/A QIAGEN N.V. Filed by: WELLINGTON MANAGEMENT GROUP LLP

Form 6-K QIAGEN N.V. For: Sep 30

Form 6-K QIAGEN N.V. For: Sep 30

Top News Gainers

3/3 European shares rise 2% on stimulus hopes [Reuters] 16.8%

12/26 Qiagen NV (NYSE: QGEN) had its "underperform" rating re-affirmed by analysts at Bank of America Corp. They now have a $28.00 price target on the stock. 11.0%

11/15 QIAGEN Receives Several Conditional, Non-binding Indications of Interest, Enters Into Discussions to Explore Potential Strategic Alternatives 8.5%

11/13 Qiagen up 7% on rumored Thermo Fisher interest [Seeking Alpha] 6.2%

10/9 Qiagen NV (NYSE: QGEN) was downgraded by analysts at Kepler Capital Markets from a "hold" rating to a "reduce" rating. 5.4%

1/8 Calibre Scientific Acquires NeXtal Biotechnologies to Further Expand its Protein Portfolio 5.3%

2/4 Q4/2019 12/31/2019 EPS 0.480 ZacksConsensus 0.440 ActVsEst 0.040 - Beat 5.1%

11/6 QIAGEN Launches Novel NGS Workflow for Simultaneous DNA and RNA Analysis for Use in Cancer Profiling at 2019 AMP Annual Meeting 4.2%

2/26 QIAGEN announces worldwide shipments of QIAstat-Dx test kits for SARS-CoV-2 3.9%

3/31 QIAGEN Receives U.S. FDA EUA for QIAstat-Dx test kit, First and Only Syndromic Solution Integrating Detection of SARS-CoV-2 Coronavirus 2.7%

Top News Decliners

10/7 QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests -18.0%

5/6 Q1/2019 3/31/2019 EPS 0.270 ZacksConsensus 0.260 ActVsEst 0.010 - Beat -5.2%

3/11 Is This The Next Major Roadblock To The White House's Coronavirus Response? [zero hedge] -4.2%

7/24 Q2/2019 6/30/2019 EPS 0.330 ZacksConsensus N/A ActVsEst N/A - N/A -4.1%

11/18 Europe markets mostly higher as US-China trade talks dominate sentiment; Qiagen up 13% [CNBC] -3.2%

9/30 QIAGEN Launches Enhanced GeneGlobe Design & Analysis Hub, Combining Curated Knowledge, Content-based Assays and Analyses for Life Science Research -3.1%

2/5 Qiagen NV (NYSE: QGEN) had its "neutral" rating re-affirmed by analysts at Barclays PLC. -2.4%

3/18 Severe shortages of swabs and other supplies hamper testing [CNN] -2.2%

1/20 UPDATE 1-European shares dip as investors eye PMI data, ECB meeting [Reuters (UK)] -2.1%

8/20 Qiagen NV (NYSE: QGEN) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -1.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day